Ohio Public Employees Retirement System (OPERS)’s BridgeBio Pharma BBIO Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-43,958	Closed	-$335K	–	1994
2022 Q4	$335K	Buy	43,958 +2,908	+7%	+$27.8K	﹤0.01%	1335
2022 Q3	$408K	Buy	+41,050	New	+$426K	﹤0.01%	1357
2022 Q1	–	Sell	-3,728	Closed	-$62K	–	2013
2021 Q4	$62K	Buy	3,728 +399	+12%	+$16.9K	﹤0.01%	1854
2021 Q3	$156K	Buy	3,329 +588	+21%	+$31.5K	﹤0.01%	1584
2021 Q2	$167K	Buy	+2,741	New	+$157K	﹤0.01%	1556

Other funds holding BBIO

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s BBIO Position: Q1 2023 in Review

Ohio Public Employees Retirement System (OPERS) sold out of BridgeBio Pharma (BBIO) in Q1 2023, closing a stake of 43,958 shares — an estimated $335K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in BBIO in Q2 2021 and held it in 5 quarters. The position peaked at $408K in Q3 2022. 213 funds tracked by Wall St. Rank hold BBIO as of Q1 2023.

Ohio Public Employees Retirement System (OPERS) reported no remaining BridgeBio Pharma position as of Q1 2023 after selling out during the quarter.
Ohio Public Employees Retirement System (OPERS) sold 43,958 BridgeBio Pharma shares in Q1 2023, an estimated $335K.
Ohio Public Employees Retirement System (OPERS) first reported a position in BridgeBio Pharma in Q2 2021 and held it in 5 quarters.
Ohio Public Employees Retirement System (OPERS)'s BridgeBio Pharma position peaked at $408K in Q3 2022.
213 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2023.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2023, filed 15 May 2023.